Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.540
-0.130 (-2.78%)
Sep 10, 2026, 9:42 AM EDT - Market open
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $269.61 million as of September 10, 2026. Its market cap has decreased by -17.34% in one year.
Market Cap
269.61M
Enterprise Value
145.13M
1-Year Change
-17.34%
Ranking
Category
Stock Price
$4.54
ChartMarket Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $269.61M, a decrease of -52.32%. That is a compound annual growth rate of -11.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 286.83M | -6.07% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 305.33M |
| Bicycle Therapeutics | 300.97M |
| Fate Therapeutics | 297.15M |
| Clinuvel Pharmaceuticals | 297.02M |
| Fulcrum Therapeutics | 293.74M |
| ProQR Therapeutics | 292.12M |
| Turn Therapeutics | 291.92M |
| AC Immune | 284.36M |